NCT05388123
- Conditions
- Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Scripps Cancer Center La Jolla, California, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,121 public trials
2,033 recruiting studies
Lymphoproliferative Disorders trial results
NCT02783625
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- University of Washington School of Medicine in St. Louis St Louis, Missouri, United States
- Washington University School of Medicine St Louis, Missouri, United States
NCT02661542
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Completed
A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma
NCT02316106
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Little Rock, Arkansas, United States
- Jacksonville, Florida, United States
- West Palm Beach, Florida, United States
- Atlanta, Georgia, United States
NCT03593018
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +6 more
- Locations
-
- University Hospital for Internal Medicine - University Hospital Graz Graz, Austria
- Medical University of Vienna Vienna, Austria
- A. Z. Sint-Jan Brugge-Oostende AV Bruges, Belgium
- Cliniques Universitaires de Bruxelles - Hôpital Erasme Brussels, Belgium
NCT05683834
- Conditions
- DNA Virus Infections, Epstein-Barr Virus Infection, Epstein-Barr Virus Infections, +18 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- University of Minnesota Minneapolis, Minnesota, United States
Completed
Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)
NCT02433795
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Chonbuk National University Hospital Jeonju, Jeollabuk-do, South Korea
- Hallym University Medical Center Anyang-si, South Korea
- Chungnam National University Daejeon, South Korea
- Gachon University Gil Medical Center Incheon, South Korea
Completed
Safety of Clofarabine With Multiagent Chemotherapy in Childhood Acute Lymphoblastic Leukemia
NCT01279096
- Conditions
- Acute Lymphoid Leukemia Relapse, Acute Lymphoid Leukemia Relapse After Bone Marrow Transplant, Disease Attributes, +14 more
- Locations
-
- Besançon University Hospital Besançon, France
- Lille University Hospital Lille, France
NCT03623373
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT03213678
- Conditions
- Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, +82 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States